Literature DB >> 19052726

Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice.

J Kitanaka1, N Kitanaka, T Tatsuta, F S Hall, G R Uhl, K Tanaka, N Nishiyama, Y Morita, M Takemura.   

Abstract

OBJECTIVE: The effects of sigma receptor antagonists on methamphetamine (METH)-induced stereotypy have not been examined. We examined the effects of sigma antagonists on METH-induced stereotypy in mice.
RESULTS: The administration of METH (10 mg/kg) to male ddY mice induced stereotyped behavior consisting of biting (90.1%), sniffing (4.2%), head bobbing (4.1%), and circling (1.7%) during an observation period of 1 h. Pretreatment of the mice with BMY 14802 (alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazinebutanol; 1, 5, and 10 mg/kg), a non-specific sigma receptor antagonist, significantly increased METH-induced sniffing (19.2%, 30.5%, and 43.8% of total stereotypical behavior) but decreased biting (76.6%, 66.9%, and 49.3% of total stereotypical behavior) in a dose-dependent manner. This response was completely abolished by (+)-SKF 10,047 ([2S-(2alpha,6alpha,11R)]-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(2-propenyl)-2,6-methano-3-benzazocin-8-ol; 4 and 10 mg/kg), a putative sigma(1) receptor agonist, and partially by PB 28 (1-cyclohexyl-4-[3-(1,2,3,4-tetrahydro-5-methoxy-1-naphthalen-1-yl)-n-propyl]piperazine; 1 and 10 mg/kg), a putative sigma(2) receptor agonist. The BMY 14802 action on METH-induced stereotypy was mimicked by BD 1047 (N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(dimethylamino)ethylamine; 10 mg/kg), a putative sigma(1) receptor antagonist, but not by SM-21 ((+/-)-tropanyl 2-(4-chlorophenoxy)butanoate; 1 mg/kg), a putative sigma(2) receptor antagonist. The BD 1047 effect on METH-induced stereotypy was also abolished completely by (+)-SKF 10,047 and partially by PB 28. The overall frequency of METH-induced stereotypical behavior was unchanged with these sigma receptor ligands, despite the alteration in particular behavioral patterns. The BMY 14802 action on METH-induced stereotypy was unaffected by pretreatment with centrally acting histamine H(1) receptor antagonists (pyrilamine or ketotifen, 10 mg/kg), suggesting that these effects are independent of histamine H(1) receptor signaling systems.
CONCLUSION: In summary, modulation of central sigma(1) receptors alters the pattern of METH-induced stereotypy, producing a shift from stereotypical biting to stereotypical sniffing, without affecting the overall frequency of stereotypical behavior.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19052726      PMCID: PMC3157915          DOI: 10.1007/s00213-008-1425-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  64 in total

1.  Effects of D-amphetamine on defensive behaviors related to fear and anxiety.

Authors:  Chris M Markham; Mu Yang; Robert J Blanchard; D Caroline Blanchard
Journal:  Pharmacol Biochem Behav       Date:  2006-04-19       Impact factor: 3.533

Review 2.  [Toxicity of an alkaloid extracted from the plant Lobelia inflata: association with methamphetamine-induced behavioral abnormalities].

Authors:  Junichi Kitanaka
Journal:  Chudoku Kenkyu       Date:  2008-04

Review 3.  Sigma receptors: biology and function.

Authors:  J M Walker; W D Bowen; F O Walker; R R Matsumoto; B De Costa; K C Rice
Journal:  Pharmacol Rev       Date:  1990-12       Impact factor: 25.468

4.  2-Phenylethylamine in combination with l-deprenyl lowers the striatal level of dopamine and prolongs the duration of the stereotypy in mice.

Authors:  Junichi Kitanaka; Nobue Kitanaka; Tomohiro Tatsuta; Motohiko Takemura
Journal:  Pharmacol Biochem Behav       Date:  2005-11-18       Impact factor: 3.533

5.  Sigma(2)-receptor regulation of dopamine transporter via activation of protein kinase C.

Authors:  Alicia E Derbez; Rupal M Mody; Linda L Werling
Journal:  J Pharmacol Exp Ther       Date:  2002-04       Impact factor: 4.030

6.  Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.

Authors:  B L Largent; A L Gundlach; S H Snyder
Journal:  J Pharmacol Exp Ther       Date:  1986-08       Impact factor: 4.030

Review 7.  Dopaminergic mechanisms in idiopathic and drug-induced psychoses.

Authors:  J A Lieberman; B J Kinon; A D Loebel
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

8.  Animal models with potential applications for screening compounds for the treatment of obsessive-compulsive disorder.

Authors:  A Woods-Kettelberger; S Kongsamut; C P Smith; J T Winslow; R Corbett
Journal:  Expert Opin Investig Drugs       Date:  1997-10       Impact factor: 6.206

9.  Motor effects of two sigma ligands mediated by nigrostriatal dopamine neurons.

Authors:  S R Goldstein; R R Matsumoto; T L Thompson; R L Patrick; W D Bowen; J M Walker
Journal:  Synapse       Date:  1989       Impact factor: 2.562

10.  Modulation of amphetamine-stimulated (transporter mediated) dopamine release in vitro by sigma2 receptor agonists and antagonists.

Authors:  S Izenwasser; D Thompson-Montgomery; S E Deben; I N Chowdhury; L L Werling
Journal:  Eur J Pharmacol       Date:  1998-04-10       Impact factor: 4.432

View more
  12 in total

Review 1.  The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction.

Authors:  Danielle O Sambo; Joseph J Lebowitz; Habibeh Khoshbouei
Journal:  Pharmacol Ther       Date:  2018-01-31       Impact factor: 12.310

2.  Targeting sigma receptors: novel medication development for drug abuse and addiction.

Authors:  Rae R Matsumoto
Journal:  Expert Rev Clin Pharmacol       Date:  2009-07       Impact factor: 5.045

3.  M100907 and BD 1047 attenuate the acute toxic effects of methamphetamine.

Authors:  Azizi Ray; Clinton E Canal; J Christopher Ehlen; Kenner C Rice; Kevin Sean Murnane
Journal:  Neurotoxicology       Date:  2019-06-01       Impact factor: 4.294

4.  Inhibition of sigma-1 receptor reduces N-methyl-D-aspartate induced neuronal injury in methamphetamine-exposed and -naive hippocampi.

Authors:  Katherine J Smith; Tracy R Butler; Mark A Prendergast
Journal:  Neurosci Lett       Date:  2010-06-30       Impact factor: 3.046

5.  Regulation of sigma-1 receptors and endoplasmic reticulum chaperones in the brain of methamphetamine self-administering rats.

Authors:  Teruo Hayashi; Zuzana Justinova; Eri Hayashi; Gianfrancesco Cormaci; Tomohisa Mori; Shang-Yi Tsai; Chanel Barnes; Steven R Goldberg; Tsung-Ping Su
Journal:  J Pharmacol Exp Ther       Date:  2009-11-25       Impact factor: 4.030

Review 6.  The pharmacology of sigma-1 receptors.

Authors:  Tangui Maurice; Tsung-Ping Su
Journal:  Pharmacol Ther       Date:  2009-07-18       Impact factor: 12.310

7.  Straub tail reaction in mice treated with σ(1) receptor antagonist in combination with methamphetamine.

Authors:  Junichi Kitanaka; Nobue Kitanaka; F Scott Hall; George R Uhl; Koh-Ichi Tanaka; Nobuyoshi Nishiyama; Motohiko Takemura
Journal:  Brain Res       Date:  2012-09-08       Impact factor: 3.252

Review 8.  The sigma-1 receptor: roles in neuronal plasticity and disease.

Authors:  Saïd Kourrich; Tsung-Ping Su; Michiko Fujimoto; Antonello Bonci
Journal:  Trends Neurosci       Date:  2012-10-23       Impact factor: 13.837

Review 9.  Sigma Receptors and Substance Use Disorders.

Authors:  Valentina Sabino; Callum Hicks; Pietro Cottone
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 3.650

10.  Pretreatment or Posttreatment with Aripiprazole Attenuates Methamphetamine-induced Stereotyped Behavior in Mice.

Authors:  Nobue Kitanaka; Junichi Kitanaka; F Scott Hall; Masaru Kayama; Hironobu Sugimori; George R Uhl; Motohiko Takemura
Journal:  J Exp Neurosci       Date:  2015-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.